# HAZLEHURST v. SECRETARY OF HEALTH AND HUMAN SERVICES

> United States Court of Federal Claims · July 16, 2025

URL: https://www.frixlaw.com/law-library/cases/11101498

## Case

- **Court:** United States Court of Federal Claims
- **Decided:** July 16, 2025
- **Precedential status:** Published
- **Opinion:** Opinion
- **Judges:** Edward H. Meyers
- **Cited by:** 0 later opinions in the Frix Law Library

## Citator (automated)

- No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases.
- Full citator and citing cases: https://www.frixlaw.com/law-library/cases/11101498

## How later opinions describe it (automated extraction)

- finding allegations that amount to a failure to disclose information that would have helped an opposing party’s defense insufficient for fraud 19 on the court because it “[a]t best” went to witness credibility, not to any miscarriage of justice
- explaining “[o]ut of deference to the deep[-]rooted policy in favor of the repose of judgments . . . , courts[] have been cautious” when analyzing fraud on the court claims
- explaining that the Special Master “accord[ed] little weight” to the evidence because of the study’s severe and several shortcomings
- rejecting a constitutional challenge to the Act
- finding allegations of witness threats and improper attorney influence on witnesses insufficient for fraud on the court without proof of outcome alteration

## Opinion text

In the United States Court of Federal Claims
No. 03-654
Filed: June 26, 2025
Reissued: July 16, 2025 1
________________________________________
)
ROLF HAZLEHURST, Parent and Conservator )
for WILLIAM YATES HAZLEHURST, )
)
Petitioner, )
)
v. )
)
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Defendant. )
________________________________________ )

Rolf G.S. Hazlehurst, Children’s Health Defense, Jackson, TN, for Petitioner, with whom was
Kimberly M. Mack Rosenberg, Mack Rosenberg Law LLC, Princeton, NJ, of counsel.

Voris Edward Johnson, Jr., Assistant Director, United States Department of Justice, Torts
Branch, Civil Division, Washington, D.C., with whom were Brian M. Boynton, Principal Deputy
Assistant Attorney General, C. Salvatore D’Alessio, Director, Torts Branch, Civil Division,
Heather L. Pearlman, Deputy Director, Torts Branch, Civil Division, and Alexis B. Babcock,
Assistant Director, Torts Branch, Civil Division.

OPINION AND ORDER

MEYERS, Judge.

Many cases have come to this court alleging that certain vaccines cause autism. These
cases were initially handled in omnibus proceedings with different test cases presenting different
causation theories. This case was one of the test cases regarding whether the Measles-Mumps-
Rubella (“MMR”) vaccine caused autism. In 2009, this court entered judgment on behalf of the
United States, and the Federal Circuit affirmed that judgment. In fact, the Government won
virtually all autism cases brought to the court.

Now, 16 years later, the Petitioner contends that the United States got those judgments
through a coordinated series of frauds on the court and seeks to set aside the judgment. The crux
of the alleged fraud is that the Government concealed that one of its experts thought vaccines

1
The court previously issued this Opinion and Order to the Parties on June 26, 2025, and,
pursuant to Vaccine Rule 18(b), gave them 14 days to propose redactions. Because they did not
propose any, the court reissues this Opinion and Order in its entirety.
could cause autism and made false representations to the court that he did not. Because the
Petitioner has failed to carry his heavy burden of establishing fraud on the court, the court denies
his motion for relief from the final judgment.

To be clear, the Petitioner’s motion does not call on this court to consider the veracity of
his belief that a vaccination caused his autism. The court has no doubt that his belief is sincere.
And there are certainly persistent voices in the scientific and political arenas that continue to
assert that vaccines cause or contribute to autism. Whatever the merit of these arguments, they
are not the issue before this court today. The court today addresses only whether the United
States Department of Justice committed a fraud on the court to prevail in this case. It did not.

I. Background

A. The National Childhood Vaccine Injury Act

The 20th century witnessed remarkable progress in public health. One of its “greatest”
achievements was “the elimination of communicable diseases through vaccination.” Bruesewitz
v. Wyeth LLC, 562 U.S. 223, 226 (2011) (citations omitted); H.R. Rep. No. 99-908, at 4 (1986)
(explaining that the “[v]accination of children against deadly, disabling, but preventable
infectious diseases has been one of the most spectacularly effective public health initiatives this
country has ever undertaken[,] . . . prevent[ing] thousands of children’s deaths each year and
[saving] [b]illions of medical and health-related dollars”).

In fact, the vaccination regime became “so effective in preventing infectious diseases that
the public became less alarmed at the threat of those diseases, and much more concerned with
the risk of injury from the vaccines themselves.” Bruesewitz, 562 U.S. at 226 (footnote omitted);
see also Terran v. Sec’y of Health & Hum. Servs., 195 F.3d 1302, 1306–07 (Fed. Cir. 1999)
(noting the “risk” that “[c]hildhood vaccinations . . . can cause serious [although relatively rare]
adverse effects”), cert. denied sub nom. Terran v. Shalala, 531 U.S. 812 (2000). So began “a
massive increase in vaccine-related tort litigation.” Bruesewitz, 562 U.S. at 227. That litigation
created concerns that litigation costs and the potential financial liability might drive
manufacturers from the vaccine market altogether. Terran, 195 F.3d at 1307. To make matters
worse, aggrieved families struggled to get compensation for legitimate vaccine-related injuries.
Bruesewitz, 562 U.S. at 227 (citations omitted). These concerns “threatened to depress
vaccination rates[,] . . . a source of concern to public health officials, [because] vaccines are
effective in preventing outbreaks of disease only if a large percentage of the population is
vaccinated.” Id.

Congress responded with the National Childhood Vaccine Injury Act of 1986 (the
“Vaccine Act” or “Act”). 42 U.S.C. §§ 300aa-1–300aa-34. The Act worked to stabilize the
vaccine market by reducing litigation risks and encouraging the development of safer vaccines.
H.R. Rep. No. 99-908, at 4 (1986) (“[T]he Committee expects that a greater number of
manufacturers will enter the vaccine market and that a greater number of vaccine products will
become available to prevent disease, reduce reactions, and otherwise improve public health.”).

To achieve these objectives, the Act (1) created the Office of Special Masters (“OSM”)
within the United States Court of Federal Claims, and (2) established the National Vaccine

2
Injury Compensation Program (“NVICP”). See 42 U.S.C. §§ 300aa-10(a), -12(c). The NVICP
is a “no-fault compensation program ‘designed to work faster and with greater ease than the civil
tort system.’” Bruesewitz, 562 U.S. at 228 (quoting Shalala v. Whitecotton, 514 U.S. 268, 269
(1995)). People injured by vaccines need not prove a product defect or inadequate labeling to
receive compensation, as a normal tort action would require. At its core, the Act aimed for a
quick, straightforward adjudication process. Id.

The Act’s Vaccine Injury Table facilitates the quick adjudication of many of these
claims. The Secretary maintains a table that identifies for each covered vaccine the common
compensable injuries and the timeframe of onset of symptoms following vaccination. These are
known as “Table” injuries. 42 U.S.C. § 300aa-14; Bruesewitz, 562 U.S. at 228. “Claimants who
show that a listed injury first manifested itself at the appropriate time are prima facie entitled to
compensation.” Bruesewitz, 562 U.S. at 228 (citing 42 U.S.C. §§ 300aa-11(c)(1), -13(a)(1)(A)).
Claimants with Table injuries need not prove causation; it is assumed once the claimant
identifies the vaccination and establishes the onset of symptoms within the appropriate time after
vaccination.

If, however, the claimed injury is not a Table injury or did not occur within the specified
time frame, claimants must prove causation (these are known as “Off-Table” injuries). 42
U.S.C. § 300aa-11(c)(1)(C)(ii); Bruesewitz, 562 U.S. at 228–29. Successful claimants receive
compensation for several categories of damages. 42 U.S.C. § 300aa-15. Attorney’s fees are
provided, too. Id. § 300aa-15(e). Awards are paid via a fund created by excise taxes levied on
each vaccination. Id. § 300aa-15(i)(2). The Act was “designed to stabilize the vaccine market.”
Bruesewitz, 562 U.S. at 229. Vaccine manufacturers now possess “significant tort-liability
protections,” including general immunity from liability for certain injuries, provided they comply
with applicable regulatory requirements and issue appropriate warnings. Id. (citing 42 U.S.C.
§ 300aa-22(b)–(c)).

So, to receive compensation under the Act, a petitioner must demonstrate, by a
preponderance of the evidence, that he or she received a covered vaccine and either (1) suffered
a Table injury within the requisite time frame, or (2) suffered an injury or aggravation of a
preexisting injury or condition not on the Table “‘but which was caused’ by a covered vaccine.” 2
Canuto v. Sec’y of Health & Hum. Servs., 660 F. App’x 955, 957 (Fed. Cir. 2016) (emphasis
omitted) (quoting 42 U.S.C. §§ 300aa-11(c)(1)(C), -14; 42 C.F.R. § 100.3).

2
To prove actual causation, petitioners must, by a preponderance of the evidence, demonstrate
“that the vaccination brought about [the] injury.” Althen v. Sec’y of Health Hum. Servs., 418
F.3d 1274, 1278 (Fed. Cir. 2005). They must provide “(1) a medical theory causally connecting
the vaccination and the injury; (2) a logical sequence of cause and effect showing that the
vaccination was the reason for the injury; and (3) a showing of a proximate temporal relationship
between vaccination and injury.” Id. A petitioner must prove causation “by medical literature or
by the medical opinion of an expert witness. If the petitioner meets this burden, they are entitled
to recover under the Vaccine Act unless the government is able to prove—by preponderant
evidence—that the injury was caused by factors unrelated to the vaccination.” Canuto, 660 F.
App’x at 957 (citations omitted).

3
B. The Omnibus Autism Proceedings

In July 2002, the OSM confronted thousands of petitions alleging that vaccines cause
3
autism. To efficiently manage these cases, the OSM, with input from counsel representing
various petitioners, created the Omnibus Autism Proceedings (“OAP”). 4 Cedillo v. Sec’y of
Health & Hum. Servs., 617 F.3d 1328, 1334 (Fed. Cir. 2010); see also In re Claims for Vaccine
Injs. Resulting in Autism Spectrum Disorder or a Similar Neurodevelopmental Disorder, 2002
WL 31696785, at *1 (Fed. Cl. Spec. Mstr. July 3, 2002) [hereinafter Autism General Order #1].
More than 5,000 petitions made their way to the OAP, the proceedings designed to determine
whether a relationship exists between certain vaccines and autism. Hazlehurst v. Sec’y of Health
& Hum. Servs., 604 F.3d 1343, 1345 (Fed. Cir. 2010). Autism General Order #1 outlined the
OAP’s background and how it would proceed.

The Chief Special Master, various petitioners’ legal counsel, and medical representatives
from the Department of Health and Human Services (“HHS”) developed the process that would
resolve the claims. Autism General Order #1, at *1–3. At the outset, the OSM “authorize[d] a
team of attorneys to represent the interests of all petitioners”—the Petitioners’ Steering
Committee (“PSC”). Id. at *3. The PSC requested and received extensive discovery so, in its
words, the “science [could] crystalize.” Id. at *2. Such discovery occurred from 2002 to 2006.
See King v. Sec’y of Health & Hum. Servs., No. 03-584V, 2010 WL 892296, at *7 (Fed. Cl.
Spec. Mstr. Mar. 12, 2010). The OAP would then move forward in two steps, with Special
Master Hastings, Special Master Campbell-Smith, and Special Master Vowell presiding. See
Autism General Order #1, at *3 (designating Special Master Hastings to preside over the OAP);
Hazlehurst v. Sec’y of Health & Hum. Servs., No. 03-654V, 2009 WL 332306, at *3 (Fed. Cl.
Spec. Mstr. Feb. 12, 2009) (explaining that Special Masters Campbell-Smith and Vowell were
added to the OAP), aff’d, 88 Fed. Cl. 473 (2009), aff’d, 604 F.3d 1343 (Fed. Cir. 2010).

In Step 1, the OSM would inquire into the general causation issues in the cases. That is,
“whether the vaccinations in question can cause autism and/or similar disorders, and if so in what
circumstances.” Autism General Order #1, at *2. In Step 2, the OSM would apply the
conclusions reached in Step 1 “to decide the specific causation question of whether the received

3
Autism is “a brain disorder affecting a person’s ability to communicate, form relationships,
and/or respond appropriately to the environment.” In re Claims for Vaccine Injs. Resulting in
Autism Spectrum Disorder or a Similar Neurodevelopmental Disorder, 2002 WL 31696785, at
*1 n.2 (Fed. Cl. Spec. Mstr. July 3, 2002).
4
Omnibus programs are nothing new. They have been “used previously in Vaccine Act cases to
make causation determinations in groups of cases alleging that a particular vaccine caused a
specific injury, but the OAP was, by far, the largest grouping of similar cases.” R.K. v. Sec’y of
Health & Hum. Servs., No. 03-0632V, 2015 WL 10911950, at *2 (Fed. Cl. Spec. Mstr. Sept. 28,
2015), motion for review denied, 125 Fed. Cl. 57 (2016), aff’d per curiam, 671 F. App’x 792
(Fed. Cir. 2016).

4
vaccinations did cause the autistic condition alleged in each of the individual cases.” Hazlehurst,
2009 WL 332306, at *2 (emphasis omitted).

To present general causation evidence, the PSC proposed—and the OSM permitted—a
test case approach. The test cases would address three main theories: (1) whether a combination
of the MMR vaccine and thimerosal-containing vaccines (“TCVs”) could cause autism; (2)
whether the MMR vaccine alone could cause autism; and (3) whether TCVs alone could cause
autism. See Autism General Order #1, at *5. 5

Throughout the OAP, a vast body of medical and scientific evidence was produced,
“easily . . . the largest of all cases presented to the [c]ourt in the history of the Vaccine Act.”
Cedillo v. Sec’y of Health & Hum. Servs., 89 Fed. Cl. 158, 167 (2009), aff’d, 617 F.3d 1328
(Fed. Cir. 2010). “[T]he three special masters who heard this evidence [found] that the issue of
[vaccine] causation was not a ‘close call.’” Blake v. Sec’y of Health & Hum. Servs., No. 03-31V,
2014 WL 2769979, at *14 n.34 (Fed. Cl. Spec. Mstr. May 21, 2014). They each “independently
determined that the medical theories advanced were not reliable and that the test case petitioners
had failed to produce preponderant evidence” of causation. Id. Litigation concluded in 2010,
when the Federal Circuit affirmed the dismissal of Cedillo. 6 The court turns now to the details of
the OAP test cases.

1. Theory 1

The three Theory 1 test cases were Cedillo, Hazlehurst, and Snyder. The OSM, this
court, and Court of Appeals for the Federal Circuit each rejected the PSC’s causation theories
Cedillo and Hazlehurst. See Cedillo v. Sec’y of Health & Hum. Servs., No. 98-916V, 2009 WL
331968 (Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d, 89 Fed. Cl. 158 (2009), aff’d, 617 F.3d 1328
(Fed. Cir. 2010); Hazlehurst v. Sec’y of Health & Hum. Servs., No. 03-654V, 2009 WL 332306
(Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d, 88 Fed. Cl. 473 (2009), aff’d, 604 F.3d 1343 (Fed.
Cir. 2010). The OSM and this court rejected the claims in Snyder, which was not appealed to the
Federal Circuit. Snyder v. Sec’y of Health & Hum. Servs., No. 01-162V, 2009 WL 332044 (Fed.
Cl. Spec. Mstr. Feb. 12, 2009), motion for review denied, 88 Fed. Cl. 706 (2009). To provide
context for the Petitioner’s motion, the court summarizes the Theory 1 test cases.

5
Autism General Order #1 included one specific note, a “caveat,” addressed further below, but
explained here. Autism General Order #1, at *6. Some cases would invariably involve “autistic-
like disorders which manifested following an injury defined in the Vaccine Injury Table.” Id.
For example, “a vaccinee may have suffered an episode involving a severe acute encephalopathy
within 72 hours after a pertussis vaccination (DTP or DTaP) [types of TCVs], or 5 to 15 days
after an MMR vaccination.” Id. If that happened, “such an acute encephalopathy and any
residual effects thereof would be presumed to be vaccine-caused pursuant to the Vaccine Injury
Table” if “the vaccinee suffered a sudden, dramatic, and severe change in level of consciousness
lasting at least 24 hours.” Id. (citations omitted). So the injury would “be processed . . . as a
Table injury.” Id.
6
The Federal Circuit affirmed the dismissals of Hazlehurst on May 13, 2010, and Cedillo on
August 27, 2010.

5
a) Cedillo

The first test case considered whether a combination of TCVs and the MMR vaccine
caused Michelle Cedillo’s autism, mental retardation, and seizures. Cedillo, 2009 WL 331968,
at *1. Michelle was born in 1994. Id. at *4. The pregnancy and birth were “uncomplicated,” as
were her pediatric visits during the first sixteen months of her life. Id. She received the routine
childhood vaccines, including, at fifteen months, an MMR vaccination. Id. One week after the
MMR shot, she developed a fever and a rash. Id. at *5. The fever eventually rose to 105.7
degrees. Id. And she was coughing, gagging, and vomiting. Id.

Her pediatrician prescribed antibiotics for either sinusitis or influenza. Id. She saw her
again a few months later. Id. During that appointment, the pediatrician did not note any
substantial health concerns, but did remark that Michelle was talking less since before her illness.
Id. Another month later, the pediatrician suspected “developmental delay.” Id. Subsequent
records confirmed her abnormal development, and Michelle was diagnosed with “severe
Autism,” “profound mental Retardation,” several gastrointestinal problems, and arthritis. Id. at
*5–6. She also suffered occasional seizures. Id. at *6.

The PSC argued that the effects of TCVs and the MMR vaccine caused her to regress.
Id. at *15. It claimed that the vaccines damaged Michelle’s immune system, and “due to her
immune deficiency, she was unable to clear from her body the measles virus contained in the
MMR vaccine.” Cedillo, 617 F.3d at 1335. Instead, the “measles virus persisted and replicated,”
and ultimately “invaded [her] brain,” causing inflammation and autism. Cedillo, 2009
WL331968, at *65.

Special Master Hastings presided over a hearing from June 11, 2007, to June 26, 2007.
Id. at *4 n.5. He heard general causation evidence and specific causation evidence. Id. at *10.
Six expert witnesses testified for the PSC, and nine for DOJ. Cedillo, 617 F.3d at 1335. An
extensive record amassed. Cedillo, 2009 WL331968, at *10. Michelle’s medical records
comprised nearly 8,000 pages. Id. at *14. The hearing transcript was nearly 3,000 pages. Id.
Also entered in the record were 939 medical journal articles, textbook excerpts, and other
medical literature, relating to neurology, gastroenterology, virology, immunology, molecular
biology, toxicology, genetics, and epidemiology. Id.

The PSC heavily relied on the testimony of Dr. Kinsbourne and his neuroinflammation
theory. Id. at *16. Dr. Kinsbourne testified that an immune response triggered by the measles
component of the MMR vaccine could lead to an increase of pro-inflammatory immune cells in
the brain. Id. at *65–67. He suggested this caused persistent brain inflammation, resulting in
autism. Id. Dr. Kinsbourne’s theory relied significantly on two “research articles indicating that
brain inflammation is present in autism.” Id. at *69 n.109. The articles were written by Dr.
Diana Vargas, Dr. Carlos Pardo, and Dr. Andrew Zimmerman, among others. Id. One articles
explained that the neuroinflammation research was preliminary in nature, and that the results did
not show whether such observed inflammation was harmful or beneficial. See ECF No. 120-3 at
4.

6
(1) Dr. Andrew Zimmerman

Many of the Petitioner’s fraud claims rest on Dr. Zimmerman’s role in the OAP,
beginning with the Cedillo hearing, so the court focuses on his role in that case. See ECF No.
118 at 2. DOJ retained Dr. Zimmerman “largely to counter the testimony of Dr. . . .
Kinsbourne.” ECF No. 123-3 at 4. He submitted an expert report, and DOJ initially identified
him as a testifying witness. ECF No. 131 at 8–10.

Start with his expert report. Dr. Zimmerman concluded that there was no credible basis
for the theory advanced by the PSC:

There is no scientific basis for a connection between [the MMR]
vaccine or mercury (Hg) intoxication and autism. Despite well-
intentioned and thoughtful hypotheses and widespread beliefs
about apparent connections with autism and regression, there is no
sound evidence to support a causative relationship with exposure
to both, or either, MMR and/or Hg. . . .

...

Furthermore, there is no evidence of an association between autism
and the alleged reaction to MMR and Hg, and it is more likely than
not, that there is a genetic basis for autism in [Michelle].

ECF No. 120-3 at 5–7.

Now, for his testimony. To aid in his response, DOJ asked Dr. Zimmerman to attend and
observe “on the day Dr. Kinsbourne testified.” ECF No. 131 at 8. Dr. Zimmerman did attend
when Dr. Kinsbourne testified and the events of this day are at the core of the Petitioner’s
motion. During a break in the hearing, he met with DOJ attorneys “to clarify [his] written expert
opinion.” ECF No. 120-5 at 2. He explained in a later declaration that his opinion was “case
specific . . . as to Michelle Cedillo” and “not intended to be a blanket statement as to all children
and all medical science.” Id. He believed “that there were exceptions in which vaccinations
could cause autism.” Id. Those exceptions, he said, applied to “a subset of children with an
underlying mitochondrial dysfunction.” Id. In those children, “vaccine induced fever and
immune stimulation that exceeded metabolic energy reserves could, and in at least one of [his]
patients, did cause regressive encephalopathy with features of” autism. Id. Dr. Zimmerman did
not reveal the name of said patient, but did reference the case report, Developmental regression
and mitochondrial dysfunction in a child with autism (the “Poling paper”). Id. at 3. That patient
was Hannah Poling. The court addresses this report, written by Dr. Jon Poling, Dr. Richard Frye,
and Dr. Zimmerman, in detail below.

Dr. Zimmerman stated that he told DOJ that it may not want him to testify because of the
Poling paper. ECF No. 120-6 at 6. DOJ soon after “informed [him] that [he] w[as] no longer
needed as an expert witness.” Id. at 7. DOJ says it decided not to call Dr. Zimmerman to testify
because it “was concerned that Dr. Zimmerman’s testimony about [the Poling paper] would be

7
distracting, a ‘sideshow,’ because it was not relevant to the causation theory at issue” and
because it “would be redundant, given the expected testimony of other government experts.”
ECF No. 123-3 at 9. DOJ kept Dr. Zimmerman’s written report in the record, “figuring that if
the report were withdrawn, it would suggest that Dr. Zimmerman was not called because he had
changed his opinion.” Id. That said, Dr. Zimmerman did not believe that Michelle Cedillo’s
autism stemmed from mitochondrial dysfunction, as described in the Poling paper. Id. at 8–9.
Further, the PSC’s experts in Cedillo did not offer the theory that vaccines can cause autism by
the theory posited in the Poling paper—by significantly aggravating a preexisting mitochondrial
disorder. Also, Dr. Zimmerman wrote his Cedillo opinion more than one year after he co-
authored the Poling paper. Id. at 8–9. The Poling paper was published in February 2006, ECF
No. 120-6 at 2, and his expert report was submitted in April 2007, ECF No. 120-3 at 2. Finally,
everyone on the “team already knew that Dr. Zimmerman had written the Poling case note and
that he believed there were exceptional cases in which vaccinations could cause autism.” ECF
No. 123-3 at 8.

Special Master Hastings referenced Dr. Zimmerman twice in the Cedillo decision. He
first pointed to Dr. Zimmerman’s statement “that environmental factors ‘may’ be involved in the
causation of autism, in a context that implied postnatal factors.” Cedillo, 2009 WL 331968, at
*75. This reference arose in the context of describing the PSC’s reports and other testimony.
Second, he cited Dr. Zimmerman’s expert report for the point that “the evidence does not support
the proposition that the MMR vaccine can cause autism.” Id. at *84 n.135 (emphasis omitted).
Dr. Zimmerman’s opinion was “far less important than that of the respondent’s experts who did
testify.” Id.

(2) The Special Master’s Conclusion

Special Master Hastings rejected all the PSC’s arguments, concluding that the evidence
was “overwhelmingly [to the] contrary,” and that “[t]he expert witnesses presented by [DOJ]
were far better qualified, far more experienced, and far more persuasive” than the PSC’s. Id. at
*1, *134. He found the PSC’s evidence to be unreliable. Id. at *15. And he specifically noted
that DOJ’s experts expressed “serious concerns” about those studies relied on by Dr. Kinsbourne
“that would cast doubt on their purported results.” Cedillo, 89 Fed. Cl. at 170. As for Dr.
Kinsbourne, while “an unquestionably qualified witness, his testimony was unpersuasive. His
opinion lacked reliable evidentiary support.” Hazlehurst, 2009 WL 332306, at *7. 7 In fact, he
supplied no evidence for the possibility that “vaccine-strain measles virus plays any role in
causing brain inflammation in autistic persons.” Cedillo, 2009 WL 331968, at *69 n.109
(emphasis omitted). At bottom, the PSC “wholly failed to demonstrate that it is probable that the
MMR vaccine can play a role in causing chronic brain inflammation or autism.” Id. (emphasis
omitted). This court and the Federal Circuit affirmed the Special Master’s decision. Cedillo, 89
Fed. Cl. at 164, aff’d, 617 F.3d 1328 (Fed. Cir. 2010).

b) Hazlehurst

7
Under the OAP’s rules, evidence submitted in one test case would be used in the other test
cases. The description of Dr. Kinsbourne’s testimony here is of his testimony from Cedillo and
Snyder.

8
The second test case considered Yates Hazlehurst’s autism. Hazlehurst, 2009 WL
332306, at *1. The initial petition alleged that the MMR vaccine or a combination of the MMR
vaccine and TCVs caused it, but the Special Master’s decision focused on whether the MMR
vaccine alone caused Yates’s autism, because the PSC focused solely on that theory in post-
hearing briefing. Id. at *1, *161.

Yates received the standard childhood vaccinations during his first twelve months.
Hazlehurst, 88 Fed. Cl. at 476. Three days before he turned one, he received the MMR vaccine.
Id. Yates developed normally before that shot. Id. But in the month following the vaccination,
he became, in his family’s words, “wild,” “very hyperactive,” and “out of control.” Id. By
sixteen months, he “lost all meaningful speech and [] developed an obsession with letters and
numbers.” Id. He “began to experience chronic diarrhea and abdominal pain.” Id. Dr.
Zimmerman evaluated Yates early in his life and diagnosed him with regressive autism. ECF
No. 120-9 at 49–50. 8

The PSC, again, argued the measles component of the MMR vaccine caused an immune
dysfunction, resulting in persistent measles infection, chronic gastrointestinal inflammation,
neuroinflammation, and autism. Hazlehurst, 2009 WL 332306, at *19. The record, again,
contained “a wealth of evidence and . . . testimony of a number of experts.” Id. at *172. There
were more than 1,000 medical literature exhibits and fifty combined filed expert reports. Id. at
*4. Several fact and expert witnesses testified for the PSC, including Dr. Jean-Ronel Corbier,
Yates’s treating neurologist. Id. at *4–6. Remember too that under the structure of the OAP
general causation evidence applied to all test cases.

Dr. Corbier posited that a genetic predisposition coupled with environmental insult
(TCVs and the MMR vaccine) triggered Yates’s autism. Id. at *50, *162. Central to his
testimony were several studies claiming to detect persistent measles virus in vaccinated autistic
children. Id. at *162–63. His expert report discussed “genetic-metabolic conditions,” ECF No.
120-10 at 10, which the Petitioner says includes mitochondrial dysfunction, because
mitochondrial dysfunction is a genetic-metabolic condition. ECF No. 118 at 12.

(1) Dr. Zimmerman

Dr. Zimmerman played a limited role in the Hazlehurst hearing and subsequent decisions.
References to him are sparse. During cross-examination of Dr. Corbier, the following exchange
occurred:

Q: And Dr. Zimmerman, he’s a pediatric neurologist?

A: That is correct.

Q: He’s not an immunologist.

8
Yates was later diagnosed with mitochondrial dysfunction. See ECF No. 123-7 at 4–5. Even in
those patients with mitochondrial disorder, Dr. Zimmerman still recommended vaccinations. Id.
at 10.

9
A: No, he’s a neurologist, but he has studied the immunology of
autism.

Q: Do you consider him an authority on the issue [of
immunological aspects]?

A: I respect Dr. Zimmerman, and I consider him, yes, one of the
authorities, yes.

ECF No. 121-1 at 40.

During closing, a DOJ lawyer made the following statements, that the Petitioner here
takes exception to:

I did want to mention one thing about an expert, who did not
appear here, but his name was mentioned several times, and that
was Dr. Zimmerman.

Dr. Zimmerman actually has not appeared here, but he has given
evidence on this issue, and it appeared in the [Cedillo] case. I just
wanted to read briefly because his name was mentioned several
times by Petitioners in this matter. What his views were on these
theories, and I’m going to quote from Respondent’s Exhibit FF in
the [Cedillo] case, which is part of the record in this case as I
understand it[:]

“There is no scientific basis for a connection
between measles, mumps and rubella MMR vaccine
or mercury intoxication in autism despite well-
intentioned and thoughtful hypothesis and
widespread belief about the apparent connection
with autism and regression. There’s no sound
evidence to support a causative relationship with
exposure to both or either MMR and/or mercury.”

We know his views on this issue.

ECF No. 121-4 at 4–5.

Dr. Zimmerman later stated that it was “highly misleading” for DOJ attorneys to
“continue to use [his] original written expert opinion, as to Michelle Cedillo, as evidence against
the remaining” OAP petitioners, given what he told them about the mitochondrial dysfunction
theory. ECF No. 120-5 at 4–5. He believed it was not an accurate reflection of his opinion.
ECF No. 120-6 at 9–10.

(2) The Special Master’s Conclusion

10
The Special Master referenced Dr. Zimmerman’s expert report once. She explained his
opinion that “‘there is no scientific basis for a connection’ between the MMR vaccination,
mercury intoxication, and autism,” and then stated that she relied “more heavily on the testimony
and reports of the experts who were observed and heard during the hearings.” Hazlehurst, 2009
WL 332306, at *4 n.16.

In so doing, the Special Master found the studies on which Dr. Corbier relied flawed and
unreliable due to methodological weaknesses and compromised testing systems. Id. at *132,
*136, *150. So Dr. Corbier’s opinion regarding the existence of persisting measles virus in the
gut tissue of autistic children “could not be credited as sound or reliable.” Id. at *13. And thus,
the PSC’s theory of causation was “premised upon a series of biological implausibilities.” Id. at
*149. As in Cedillo, the Special Master found the witnesses either unpersuasive, ineffective, or
unqualified due to unsound science or poor demeanor. See, e.g., id. at *7. And like Cedillo, the
Special Master found DOJ’s witnesses credible, qualified, and persuasive. See, e.g., id. at *8.
This court affirmed the OSM’s decision, and the Federal Circuit affirmed as well. See
Hazlehurst, 88 Fed. Cl. at 490, aff’d, 604 F.3d 1343 (Fed. Cir. 2010).

(3) Oral Argument at the Federal Circuit

During oral argument on appeal, the following exchange occurred between the Federal
Circuit and DOJ:

[Q:] But isn’t one of the things that the Government needs to think
about, and HHS, is whether, in fact, do you need the 95 percent
statistical probability? Do you need, at this stage, the more likely
than not, or would it suffice – or should it suffice, at this stage, if it
shown to be medically, therapeutically, scientifically possible as
one proceeds to develop the causal relationship by enhanced
procedures and the increased knowledge that are being gleaned of
what happens inside the body and the cell?

[A:] Well, there’s a lot to your question, Your Honor, but I would
say, at this stage, it – we’re not even at the stage where it’s
medically or scientifically possible. This is not a field of science
that is bereft of research. Studies have been done looking at the
causal connection between autism and MMR, autism and
Thimerosal, and every credible study has shown that there is no
causal connection.

ECF No. 122-6 at 3–4. The Petitioner challenges the DOJ lawyer’s answer, addressed below.

c) Snyder

The third Theory 1 test case considered Colten Snyder’s autism. See Snyder, 2009 WL
332044, at *1. The PSC presented the same general causation theory. Colton was developing
normally before receiving a combination of TCVs and the MMR vaccine, and those vaccines
impaired the effective functioning of his immune system. This impaired functioning allowed the
measles component of the MMR vaccine to persist causing chronic inflammation in his, which

11
led to regressive autism. Id. at *28. The PSC presented Dr. Kinsbourne and Dr. Corbier as two
of their expert witnesses. See id. at *11. The neuroinflammation theory again was offered. Id.
at *87.

Special Master Vowell rejected the claims on similar grounds to Cedillo and Hazlehurst.
See id. at *1 (explaining that the PSC’s “theories of causation were speculative and
unpersuasive,” and “[r]espondent’s experts were far more qualified, better supported by the
weight of scientific research and authority, and simply more persuasive on nearly every point in
contention”). She did reference Dr. Zimmerman several times, and “relied on his [Cedillo]
report in considering the relative merits of various interpretations of his research findings.” Id. at
*16. These references simply noted Dr. Zimmerman’s points in response to the PSC’s
witnesses’ points or cited to various papers he has authored. See id. at *49, *102, *204. She also
explained that Dr. Zimmerman’s report “clearly indicated that he did not believe the MMR
vaccine to be causal of autism.” Id. at *94 n.295.

Having explained the Theory 1 test cases, the court briefly turns to the rest of the OAP.

2. Theory 2

The three Theory 2 test cases were heard in 2008. See Dwyer v. Sec’y of Health & Hum.
Servs., No. 03-1202V, 2010 WL 892250 (Fed. Cl. Spec. Mstr. Mar. 12, 2010); King, 2010 WL
892296; Mead v. Sec’y of Health & Hum. Servs., No. 03-215V, 2010 WL 892248 (Fed. Cl. Spec.
Mstr. Mar. 12, 2010).

Dr. Kinsbourne again served as a causation expert for the PSC. See, e.g., Dwyer, 2010
WL 892250, at *5. This time, his neuroinflammation theory focused on the mercury contained
in thimerosal, rather than measles in the MMR vaccine. 9 See id. at *142. He again relied on Dr.
Pardo’s research, id. at *150, who again provided a letter that echoed concerns about misuse of
his research: “[I]t ‘is important to clarify the notion that neuroinflammatory responses are
directly associated with injury. At present, we are not able to conclude that these neurological
reactions are deleterious for the central nervous system.’” King, 2010 WL 892296, at *41
(alterations omitted). The neuroinflammation may be in fact beneficial, and “[i]t is erroneous to
assign . . . an exclusive deleterious or injury effect of those neurological responses in the CNS.”
Id. The OSM rejected the presented causation theory that TCVs alone can cause autism. See,
e.g., id. at *1. The PSC did not seek review.

3. Theory 3

The PSC decided not to pursue its third theory—that the MMR vaccine alone causes
autism—because it was addressed in the Theory 1 cases.

9
Dr. Zimmerman did not serve as an expert in the Theory 2 test cases, and his Cedillo opinion
was not part of the record.

12
4. The Poling Paper and Case

Recall that Dr. Zimmerman, during the Cedillo hearing, spoke with DOJ about a case
report he co-authored. ECF No. 120-5 at 3. That report, published more than one year before
the Cedillo hearing, analyzed a child named Hannah Poling. See ECF No. 120-6 at 44. 10
Hannah had been diagnosed with regressive autism and a mitochondrial disorder. Id. at 45. She
suffered seizures, too. Id. The paper posited that vaccinations aggravated her mitochondrial
disorder, possibly triggering or contributing to her regressive autism. 11 Id. at 46.

Hannah’s parents opted into the OAP. They sought compensation for her autism and
seizures. See Poling v. Sec’y of Health & Hum. Servs., No. 02-1466V, 2008 WL 1883059 (Fed.
Cl. Spec. Mstr. Apr. 10, 2008). The PSC designated her case as a possible Theory 2 test case
(whether TCVs alone can cause autism). ECF No. 120-8 at 3. After reviewing Hannah’s
medical records, DOJ concluded that her condition and claim met the statutory criteria for
compensation because she experienced symptoms of a developmental regression within forty-
eight hours of receiving a DTaP vaccine and within five to fifteen days of a measles vaccine.
See ECF No. 121-5 at 2–3, 7. Those symptoms met the Table requirements for a DTaP
encephalopathy and measles Table encephalopathy. See Autism General Order #1, at *6.

Because DOJ concluded her condition merited compensation, it filed a Rule 4 report on
November 9, 2007. 12 ECF No. 121-5 at 1. The report explained that Hannah’s case met the
statutory requirements under 42 U.S.C. § 300aa-11(c)(1)(C)(ii). Id. at 7. That provision
addresses compensation for injuries caused by a vaccine on the schedule but that were either not
on the Vaccine Injury Table or did not occur within the relevant time period. 42 U.S.C. § 300aa-
11(c)(1)(C)(ii). The Polings and DOJ, however, disagreed about whether Hannah’s seizures
stemmed from her vaccines. ECF No. 121-5 at 7. So Dr. Zimmerman filed a report on
November 30, 2007, which opined that her seizures stemmed from the vaccines and that TCVs
can cause regressive autism in children with mitochondrial disorders, like Hannah. ECF No.
121-7 at 5–6. The report also concluded that “the cause of the regressive encephalopathy in
Hannah . . . was underlying mitochondrial dysfunction.” Id. at 6.

10
The record contains a copy of the paper, which can be found at the following citation: Jon S.
Poling, Richard E. Frye, John Shoffner, Andrew W. Zimmerman, Developmental regression and
mitochondrial dysfunction in a child with autism, 21 J. Child Neurology 170–72 (2006). The
authors of the Poling paper were widely criticized. The Editor-in-Chief of the Journal of Child
Neurology was frustrated because the child analyzed was one of the author’s children, and that
there was a pending Vaccine Act compensation claim. See R.K., 2015 WL 10911950, at *16.
11
The paper was listed on Dr. Zimmerman’s CV submitted by DOJ. ECF No. 120-2 at 7. The
paper was filed as an exhibit in June 2007—the middle of the Cedillo hearing, and four months
before the Hazlehurst hearing began. Furthermore, the PSC itself entered the report into the
record. ECF No. 123-3 at 20.
12
Vaccine Rule 4 requires DOJ and HHS “file a report setting forth a full and complete
statement of its position as to why an award should or should not be granted.”

13
DOJ then filed a supplemental Rule 4 report on February 21, 2008, conceding vaccine
injury caused her seizures, also under 42 U.S.C. § 300aa-11(c)(1)(C)(ii). Poling v. Sec’y of
Health & Hum. Servs., No. 02-1466 (Fed. Cl. Spec. Mstr. Feb. 21, 2008), ECF No. 27. HHS
also filed a memorandum in the case. Poling, No. 02-1466, ECF No. 52.

The Parties have expended a lot of ink on the basis for the Poling concession—i.e.,
whether the Government conceded it as an Off-Table case (meaning that the Polings proved
causation) or a Table case in which the Government presumed causation. Their disagreement
stems largely from the fact that the initial Rule 4 report was leaked. ECF No. 131 at 18.
Disclosure, however, was barred by statute unless both parties consented. 42 U.S.C. § 300aa-
12(d)(4)(A). After the leak, the Polings moved for “Complete Transparency of the Proceedings,”
arguing that the parties or their representatives should be able “to freely discuss with any person
each and every aspect of [the Poling] case, including details of the Respondent’s concession that
Hannah is entitled to compensation for her vaccine-related injuries, including her autism.” ECF
No. 121-10 at 4–5. In Poling, Special Master Campbell-Smith (who presided over the Poling
case as well as this case) deferred ruling on the motion for sixty days. Id. at 1. She considered
the motion moot because of the “unauthorized disclosure,” and deferred ruling on the motion to
allow time for the parties to come to an agreement. Id. at 20–21. No agreement was reached.
According to the Petitioner here, DOJ “change[d] the basis of compensation from [cause-in-fact],
in which causation must be proven by [a preponderance of the evidence], to a [presumptive]
‘table injury,’ in which causation is presumed.” ECF No. 118 at 36.

In the end, Special Master Campbell-Smith—who was fully aware of the dispute and had
all of the filings before her—issued a decision in Poling awarding attorney’s fees and costs. In
it, she concluded that the Government settled Poling as a Table injury:

Respondent conceded that petitioners are entitled to compensation
based on a determination that [the minor child] suffered an injury
identified on the Vaccine Injury Table, specifically, a presumptive
MMR vaccine-related injury of an encephalopathy. [The child’s]
encephalopathy eventually manifested as a chronic encephalopathy
with features of an autism spectrum disorder and a complex partial
seizure disorder as a sequel[a].

Poling v. Sec’y of Health & Hum. Servs., No. 02-1466V, 2011 WL 678559, at *1 (Fed. Cl. Spec.
Mstr. Jan. 28, 2011) (internal footnote omitted). In other words, the Poling case “was
compensated based on the presumption of causation that attaches when the Table injury
requirements are met, not on an actual causation or causation in fact basis.” R.K., 2015 WL
10911950, at *17 (emphasis omitted).

C. Post-OAP Cases Involving Dr. Zimmerman’s Mitochondrial Theory

Several cases have explored the theory expressed in the Poling paper that vaccines
aggravated pre-existing mitochondrial dysfunction, resulting in encephalopathy and autism. For
example, in R.K., the petitioners claimed that the child’s two flu vaccines “either resulted in an
encephalopathy or significantly aggravated an existing condition [mitochondrial disorder] related
to prior vaccinations.” R.K. v. Sec’y of Health & Hum. Servs., No. 03-0632V, 2015 WL

14
10936124, at *1 (Fed. Cl. Spec. Mstr. Sept. 28, 2015). The petitioners could not show any such
condition existed. Id. at *7. Moreover, “the evidence that mitochondrial deterioration can be
linked . . . to vaccines” was tenuous at best. Id. at *80. “[I]t was abundantly clear that
petitioners’ theories of causation were speculative and unpersuasive. Respondent’s experts were
far more qualified, better supported by the weight of the scientific research and authority, and
simply more persuasive on nearly every point in contention.” Id. at *7. This court and the
Federal Circuit affirmed. R.K. v. Sec’y of Health & Hum. Servs., 125 Fed. Cl. 57, 73 (2016),
aff’d, 671 F. App’x 792 (Fed. Cir. 2016).

Dr. Zimmerman testified in Madariaga v. Secretary of Health & Human Services, No.
02-1237V, 2015 WL 6160215 (Fed. Cl. Spec. Mstr. Sept. 26, 2015). The Special Master
specifically rejected the mitochondrial hypothesis. See id. at *1. There was no evidence “other
than the anecdotally based opinions of Dr. Zimmerman” demonstrating that illnesses causing
regression in children with mitochondrial disorders result in autism. Id. at *86. The Special
Master explicitly stated, “[t]here is simply no credible evidence that inflammation caused by
vaccination plays a role in the development of regression and/or mitochondrial autism in children
with mitochondrial dysfunction.” Id. And in Murphy v. Secretary of Health & Human Services,
Dr. Zimmerman appeared as a witness. No. 05-1063V, 2016 WL 3034047, at *15–16 (Fed. Cl.
Spec. Mstr. Apr. 25, 2016), motion for review denied, 128 Fed. Cl. 348 (2016). The court did
not find the mitochondrial hypothesis persuasive. See id. at *39; see also Reed v. Sec’y of Health
& Hum. Servs., No. 08-650V, 2018 WL 6844458, at *86 (Fed. Cl. Spec. Mstr. Dec. 4, 2018)
(rejecting the mitochondrial hypothesis).

Other cases in which Dr. Zimmerman did not testify have similarly rejected the claim that
vaccines cause autism by aggravating underlying mitochondrial disorders. See Miller v. Sec’y of
Health & Hum. Servs., No. 02-235V, 2015 WL 5456093, at *41 (Fed. Cl. Spec. Mstr. Aug. 18,
2015) (noting the lack of “any reliable evidence that [the quantities of alleged ‘toxins’ in
vaccines] could cause mitochondrial dysfunction, impair mitochondrial dysfunction” or cause
autism to occur); R.V. v. Sec’y of Health & Hum. Servs., No. 08-504V, 2016 WL 3882519 (Fed.
Cl. Spec. Mstr. Feb. 19, 2016) (dismissing claims that an influenza vaccine caused
encephalopathy or aggravated a mitochondrial disorder, resulting in developmental regression),
aff’d, 127 Fed. Cl. 136 (2016), appeal dismissed, No. 16-2400, 2016 WL 11949917 (Fed. Cir.
Oct. 26, 2016).

There is one case to the contrary: Paluck v. Secretary of Health & Hum. Services, 786
F.3d 1373 (Fed. Cir. 2015). The Palucks alleged that vaccinations (including the MMR vaccine)
administered to their son, K.P., significantly aggravated his underlying mitochondrial disorder,
resulting in regressive autism. Id. at 1376–77. Dr. Frye, an expert for the Palucks and co-author
of the Poling paper, testified that mitochondrial disorders impair cellular energy production,
making patients vulnerable to oxidative stress that could exacerbate mitochondrial dysfunction
and lead to neurological injury. Id. at 1377–81. Dr. Frye explained that this neurological
deterioration occurs in two stages: first, an acute immune response, typically feverish and
symptomatic within days post-vaccination; second, a longer-term progressive neurodegeneration
unfolding over weeks and months, influenced heavily by the underlying mitochondrial
vulnerability. Id. at 1381. The Special Master initially rejected Dr. Frye’s testimony, asserting
that he failed to present a plausible medical theory linking K.P.’s mitochondrial dysfunction to
vaccine-induced injury, and imposed a two-to-three-week timeline for symptom onset. Paluck v.

15
Sec’y of Health & Hum. Servs., No. 07-889V, 2011 WL 6949326, at *2, *26–27 (Fed. Cl. Spec.
Mstr. Dec. 14, 2011), vacated, 104 Fed. Cl. 457 (2012), aff’d, 786 F.3d 1373 (Fed. Cir. 2015).

This court vacated and remanded the case because the Special Master had imposed a
heightened evidentiary burden beyond what the Vaccine Act requires. Paluck v. Sec’y of Health
& Hum. Servs., 104 Fed. Cl. 457, 480 (2012). Judge Lettow said Dr. Frye’s theory was
medically plausible, particularly given contemporary scientific literature documenting
associations between vaccination, fever, and subsequent neurodegeneration in children with
mitochondrial dysfunction. Id. at 473.

On remand, the Special Master again denied the claim. Paluck v. Sec’y of Health &
Hum. Servs., No. 07-889V, 2013 WL 2453747 (Fed. Cl. Spec. Mstr. May 10, 2013), vacated,
113 Fed. Cl. 210 (2013), aff’d, 786 F.3d 1373 (Fed. Cir. 2015). This court again reversed, and
the Federal Circuit affirmed. Paluck v. Sec’y of Health & Hum. Servs., 113 Fed. Cl. 210 (2013),
aff’d, 786 F.3d 1373 (Fed. Cir. 2015). The Special Master “misapprehend[ed Dr. Frye’s] theory
of causation” and applied an unreasonably rigid timeline for symptom onset. Paluck, 786 F.3d at
1380. 13 The Palucks had satisfied their statutory burden. Id. at 1385–86.

D. Petitioner’s Medical Malpractice Suit

Finally, the Petitioner sued Yates’s pediatrician (the one who administered the vaccines),
alleging medical malpractice and lack of informed consent. ECF No. 118 at 26. The jury found
in the doctor’s favor on both and did not reach causation. Hazlehurst v. Hays, No. C-19-38
(Tenn. Madison Cnty. Cir. Ct. Mar. 11, 2022). Dr. Zimmerman was deposed in 2016 during the
litigation. See ECF No. 120-6 at 9–11. That led to additional information and actions by the
Petitioner, starting with a letter to DOJ.

E. OPR Investigation

The Petitioner also raised his allegations directly to the DOJ before coming to court. In
September 2018, the Petitioner, along with Children’s Health Defense, sent a letter to the
Inspector General of DOJ. ECF No. 123-2 at 1–26. The letter alleged fraud on the court by DOJ
attorneys in the autism cases. Id. at 26. DOJ referred the matter to the Office of Professional
Responsibility (“OPR”). See ECF No. 123-3 at 1. OPR determined after a thorough
investigation that no fraud occurred. Id. at 1–25.

The court gives little weight to OPR’s investigation, though the Government urges it do
so. The court sometimes cites to it below.

F. Procedural History

From October 15, 2007, to October 18, 2007, Special Master Campbell-Smith presided
over a causation hearing in Hazlehurst. She denied compensation in February 2009. This court
affirmed her decision in July 2009, and the Federal Circuit affirmed in May 2010.

13
The Palucks offered the Poling paper in support of their claim. Paluck, 786 F.3d at 1379.

16
As relevant here, the Petitioner says the Tennessee state court litigation revealed
important evidence. He says he now has discovered evidence of fraud on the court “during the
OAP, the motion for review, and the appeal, which directly tainted the Supreme Court decision
in Bruesewitz.” ECF No. 118 at 8. He says “[o]nly very recently was [he] able to obtain the
necessary evidence to overcome DOJ’s previous objections to the admissibility of critical
material evidence necessary to prevail” on his claim. 14 Id.

The Petitioner moves the court to reopen the case under Rule 60(d)(3), set aside the
judgment entered against the Petitioner based on fraud upon the court, and either (1) award
compensation, (2) declare the National Childhood Vaccine Injury Act unconstitutional, (3) set
aside the OAP, or (4) grant the Petitioner the right to discovery and an evidentiary hearing. Id. at
1.

II. Standard of Review

Rule 60 of the Rules of the United States Court of Federal Claims (“RCFC”) governs
here. See RCFC 60; see also Vaccine Rule 36(a) (instructing parties who file motions for relief
under RCFC 60). That rule provides two avenues to raise fraud claims after final judgment.

RCFC 60(b) allows the court to issue relief for, among other reasons, “fraud[],
misrepresentation, or misconduct by an opposing party.” RCFC 60(b)(3). But such motions can
only be brought within one year after the entry of judgment. RCFC 60(c)(1). The Federal
Circuit affirmed Hazlehurst in 2010—more than fifteen years ago. Hazlehurst, 604 F.3d at 1345.
So Rule 60(b)(3) cannot help the Petitioner challenge that judgment through a motion filed in
2024.

Rule 60(d), on the other hand, might. The rule allows a court to “set aside a judgment for
fraud on the court.” RCFC 60(d)(3). Unlike Rule 60(b)(3), a Rule 60(d)(3) motion can be
brought at any time; there is no explicit deadline. That Rule 60(d) motions are not time-barred
means courts must define “fraud on the court” narrowly “lest [this nebulous concept] become an
open sesame to collateral attacks” not subject to Rule 60(b) reconsideration. In re Golf 255, Inc.,
652 F.3d 806, 809 (7th Cir. 2011) (quoting Oxxford Clothes XX, Inc. v. Expeditors Int’l of
Washington, Inc., 127 F.3d 574, 578 (7th Cir. 1997)); Broyhill Furniture Indus., Inc. v.
Craftmaster Furniture Corp., 12 F.3d 1080, 1085 (Fed. Cir. 1993) (quoting Great Coastal
Express, Inc. v. Int’l Brotherhood of Teamsters, 675 F.2d 1349, 1356 (4th Cir. 1982)). 15

14
He says that Dr. Zimmerman “first volunteered that the DOJ did not call him as a witness in
the OAP after he told the DOJ that vaccines did cause autism.” ECF No. 118 at 26. That
revelation “illuminated existing evidence and led to additional relevant information about DOJ
fraud and the cause of Yates’[s] neurological injuries.” Id. Accordingly, the Petitioner entered
various affidavits that he says make Dr. Zimmerman’s supplemental Poling paper admissible.
Id. at 26–27. These affidavits do not change the court’s conclusion that no fraud on the court
occurred.
15
Because the text of RCFC 60(d) and Rule 60(d) of the Federal Rules of Civil Procedure
(“FRCP”) are materially the same, this court applies precedent interpreting FRCP 60(d) as well.

17
Fraud on the court is therefore reserved solely for deliberate, egregious conduct that
fundamentally corrupts the judicial process itself. United States v. Sierra Pac. Indus., Inc., 862
F.3d 1157, 1169 (9th Cir. 2017); Broyhill Furniture, 12 F.3d at 1085–86 (explaining that fraud
on the court is “typically confined to the most egregious cases, . . . such as bribery of a judge or
juror, or improper influence exerted on the court by an attorney, in which the integrity of the
court and its ability to function impartially is directly impinged”); Hazel-Atlas Glass Co. v.
Hartford-Empire Co., 322 U.S. 238, 244–45 (1944); Aoude v. Mobil Oil Corp. (Aoude II), 892
F.2d 1115, 1118 (1st Cir. 1989). It occurs when a party clearly and convincingly demonstrates
that the other “has sentiently set in motion some unconscionable scheme calculated to interfere
with the judicial system’s ability impartially to adjudicate a matter by improperly influencing the
trier or unfairly hampering the presentation of the opposing party’s claim or defense.” Aoude II,
892 F.2d at 1118; Broyhill Furniture, 12 F.3d at 1085 (explaining that fraud on the court means
“a fraud perpetrated by officers of the court so that the judicial machinery cannot perform in the
usual manner its impartial task of adjudging cases”).

Among the seminal cases on fraud on the court is Hazel-Atlas. That case began when
Hartford applied for a glass manufacturing patent. Hazel-Atlas, 322 U.S. at 240. The Patent
Office, however, was hostile and its opposition to Hartford near “insurmountable.” Id.
Eventually, though, the Patent Office granted the patent. Id. at 241. Some time later, Hartford
sued Hazel-Atlas for patent infringement. Id. Although the district court determined that no
infringement occurred, the circuit court held there was infringement, relying heavily on an expert
article Hartford submitted during the application process that lauded the subject of Hartford’s
possible patent. Id. at 241–42. A few years later, Hazel-Atlas learned that a “Hartford lawyer
was the true author of the spurious publication.” Id. at 241. This was not known because the
lawyer had attributed the article to an “ostensibly disinterested expert.” Id. at 240. The Supreme
Court found fraud on the court because there was a “deliberately planned and carefully executed
scheme to defraud not only the Patent Office but the Circuit Court of Appeals,” too. Id. at 245.

Another “near-classic example” is Aoude. Aoude rented a service station from Mobil Oil
Corporation and operated it for several years. Aoude v. Mobil Oil Corp. (Aoude I), 862 F.2d 890,
891 (1st Cir. 1988). He then sought to acquire another Mobil franchise from an operator, John
Monahan, and needed Mobil to approve the acquisition. Id. at 891–92. When Mobil was not
inclined to approve of the acquisition, Aoude sued to compel Mobil to approve the acquisition.
And to gain leverage with Mobil, Aoude “concocted, backdated, and persuaded Monahan to
sign, a bogus purchase agreement.” Aoude II, 892 F.2d at 1116. He then attached the purchase
agreement to his complaint that sought to force Mobil to accept the agreement. Id. at 1116–17.
All the while, “Aoude and his counsel continued to act out the charade.” Id. at 1118. This was
“brazen” conduct, and a fraud on the court. Id. at 1122.

Of course, not every instance of misconduct satisfies this stringent standard. In fact, most
fall short. Perjury, nondisclosure, or even fabricated evidence—though unquestionably

Kraft, Inc. v. United States, 85 F.3d 602, 605 n.6 (Fed. Cir. 1996) (“[P]recedent interpreting the
Federal Rules of Civil Procedure applies with equal force to the comparable Rules of the Court
of Federal Claims.” (citation omitted)), opinion modified on other grounds on denial of reh’g, 96
F.3d 1428 (Fed. Cir. 1996).

18
wrongful—are normally viewed as a garden-variety fraud, addressable through standard
adversarial processes and/or a Rule 60(b)(3) motion, not a Rule 60(d)(3) motion. See Weese v.
Schukman, 98 F.3d 542 (10th Cir. 1996); Fox v. Elk Run Coal Co., 739 F.3d 131, 137–38 (4th
Cir. 2014); Great Coastal Express, 675 F.2d at 1356–57.

Importantly, “the fraud, misrepresentation[,] or conduct must have actually deceived the
court. If a court’s judgment was not influenced by the conduct at issue, the judgment should not
be set aside.” Dobyns v. United States, 127 Fed. Cl. 63, 69 (2016) (quoting In re Old Carco
LLC, 423 B.R. 40, 52 (Bankr. S.D.N.Y. 2010)), aff’d, 915 F.3d 733 (Fed. Cir. 2019). “[T]he
relevant misrepresentations must go ‘to the central issue in the case,’” “affect the outcome of the
case,” and “significantly change the picture already drawn by the previously available evidence.”
Sierra Pac., 862 F.3d at 1168 (quoting United States v. Estate of Stonehill, 660 F.3d 415, 435,
448, 952 (9th Cir. 2011); Baltia Air Lines, Inc. v. Transaction Mgmt., Inc., 98 F.3d 640, 642–43
(D.C. Cir. 1996) (explaining how the alleged fraud must factor into the court’s decision).
Finally, the court must appreciate the finality of judgments. See Hazel-Atlas, 322 U.S. at 244
(explaining “[o]ut of deference to the deep[-]rooted policy in favor of the repose of judgments
. . . , courts[] have been cautious” when analyzing fraud on the court claims). All doubts are to
be resolved in favor of the prior judgment.

For example, no fraud on the court occurred when counsel in United States v. Shaffer
Equip. Co. concealed a witness’s falsified credentials. 11 F.3d 450, 452 (4th Cir. 1993). This
did not amount to fraud on the court because the misconduct did not irreparably compromise the
proceedings. Id. at 453. Nor did a fraud on the court occur when counsel did not disclose
allegedly longstanding knowledge about asbestos dangers, undermining a defense at trial.
Wilson v. Johns-Manville Sales Corp., 873 F.2d 869, 872 (5th Cir. 1989). That is because
nondisclosure does not directly corrupt judicial proceedings—even if the conduct is “most
egregious and disturbing.” Shaffer Equipment Co., 11 F.3d at 452.

And in Great Coastal Express, the Fourth Circuit rejected a fraud on the court claim even
though the plaintiff planned and executed much of the violence underlying the lawsuit, presented
false testimony, and fabricated evidence. 675 F.2d at 1358. After all, “[p]erjury and fabricated
evidence are evils that can and should be exposed at trial, and the legal system encourages and
expects litigants to root them out as early as possible.” Id. at 1357.

Finally, consider Fox, a case about a coal miner’s widow seeking benefits under the
Black Lung Benefits Act where Elk Run’s law firm withheld certain pathology reports and failed
to disclose all relevant medical evidence to its own expert, resulting in an incomplete picture of
the plaintiff’s health, which was at issue during the litigation. 739 F.3d at 136–37. While the
conduct of the attorneys was “hardly admirable,” it “did not . . . demonstrate the commission of”
fraud on the court. Id. at 133. Concealment was not part of an intentional design to undermine
the integrity of the adjudicative process, but akin to a hardball (if unethical) tactic in the
adversarial process. Id. In short, the suppression of those expert reports, though deceptive,
amounted to “garden-variety” fraud or discovery misconduct. Id. at 135–36; see also Dobyns,
127 Fed. Cl. at 74 (finding allegations of witness threats and improper attorney influence on
witnesses insufficient for fraud on the court without proof of outcome alteration); SEC v. ESM
Grp., Inc., 835 F.2d 270, 273–74 (11th Cir. 1988) (finding allegations that amount to a failure to
disclose information that would have helped an opposing party’s defense insufficient for fraud

19
on the court because it “[a]t best” went to witness credibility, not to any miscarriage of justice);
Gleason v. Jandrucko, 860 F.2d 556, 557 (2d Cir. 1988) (explaining that “subsequently
discovered evidence of perjury by a witness and nondisclosure does not support a finding of
‘fraud on the court’”).

In sum, misrepresented or suppressed evidence usually does not amount to a fraud on the
court. When it does, the misconduct must so defile the judicial process that it calls into question
the legitimacy of the court’s decision itself, meaning that the alleged misconduct must have
fundamentally altered the outcome or impaired the affected party’s ability to fairly present its
case.

III. Discussion

The Petitioner argues DOJ committed fraud on the court when it failed to withdraw Dr.
Zimmerman’s written expert report in Cedillo even though he had clarified that he believed
vaccines could cause autism. ECF No. 118 at 1–3. That failure to withdraw, the Petitioner
argues, led to fraud on the Special Masters during the OAP, on this court, on the Court of
Appeals for the Federal Circuit, and ultimately, on the Supreme Court. Id. He also argues fraud
occurred regarding the resolution of the Poling case—whether it was as a Table injury or an Off-
Table injury. Id. at 6. Finally, he contends that the Vaccine Injury Compensation Program is
unconstitutional. The court disagrees on all counts.

A. Nothing the Petitioner alleges here establishes fraud on the court.

1. DOJ did not commit fraud on the OSM during the OAP.

The Petitioner argues the Government committed fraud on the court during the OAP
process in two ways. First, that DOJ improperly kept Dr. Zimmerman’s written opinion in the
record, concealing his true opinion. Id. at 8–14. Second, he argues that DOJ suppressed and
misrepresented the Poling concession. Id. at 14–19. Neither establishes fraud on the court.
a) DOJ did not conceal Dr. Zimmerman’s “true” opinion.

Recall that, in Cedillo, 16 DOJ submitted an expert report that Dr. Zimmerman prepared.
ECF No. 120-3. In his report, Dr. Zimmerman concluded that there was no basis for a link
between the MMR vaccine and autism. Id. at 5. Recall too that DOJ initially planned to call him
to testify during the Cedillo hearing. ECF No. 131 at 8. But it decided not to. ECF No. 120-6 at
7. The Parties disagree as to why. Dr. Zimmerman believes that DOJ did not call him to testify
because of his discussion with DOJ attorneys in which he stated his view that vaccines might
cause autism in children with underlying mitochondrial dysfunction, and that he wanted his
opinion about the link between MMR and autism to apply only to Michelle Cedillo’s case, not as
a “blanket statement.” See id. The Government says it did not call Dr. Zimmerman because his

16
The Cedillo evidence is pertinent here because under the OAP, the evidence entered in each
test case would be considered in all the test cases.

20
testimony was unnecessary. ECF No. 123-3 at 9. But the Government left Dr. Zimmerman’s
written report in the record, and later quoted from it in the closing argument in Hazlehurst.

The Petitioner argues that DOJ committed a fraud on the court by using “Dr.
Zimmerman’s written Cedillo-specific causation opinion as general causation evidence[,]
explicitly claiming that it was Dr. Zimmerman’s general causation opinion[—]in other test cases,
including [Hazlehurst], when the DOJ knew that this was not true.” ECF No. 132 at 2–3; see
ECF No. 118 at 31–32 (arguing that a fraud on the occurred in part because DOJ “quoted as
general causation evidence the exact language from Dr. Zimmerman’s opinion that Dr.
Zimmerman had clarified directly to [DOJ] as specific to the Cedillo case, and was not general
causation evidence”); ECF No. 123-2 at 6 (arguing that by hiding Dr. Zimmerman’s opinion,
“HHS and its attorneys . . . actively conspir[ed] and schem[ed] to prevent brain injured children
from obtaining their lawful remedies”). The argument rests on an alleged failure to disclose. On
the Petitioner’s reading of the relevant jurisprudence, a fraud on the court occurs “[w]hen a
lawyer fails to disclose material evidence or fails to correct a false statement of material fact or
law previously made when that particular evidence is key to determining the case’s outcome.”
ECF No. 118 at 29–30 (citing Hanover Ins. Co. v. United States, 146 Fed. Cl. 447 (2019)).

These arguments fail for several reasons. First, when he spoke with the DOJ attorneys
during the break in the Cedillo hearing, Dr. Zimmerman’s concerns about the scope of his
opinion involved his work on the Poling paper. The Poling paper, however, was already in the
trial record, listed on Dr. Zimmerman’s CV (also in the record), and was publicly available more
than one year before the hearing. ECF No. 120-2 at 8. The DOJ attorneys were clearly aware of
Dr. Zimmerman’s opinion that a vaccine caused Hannah Poling’s autism long before the Cedillo
hearing and intended to call him to testify anyway. And there is nothing in the record or in the
Petitioner’s argument to suggest that DOJ did anything to hide the Poling paper from anyone—it
was in the trial record after all.

Second, the Poling paper concerned the mitochondrial dysfunction theory, which was not
at issue in any of the test cases and “irrelevant to [P]etitioner’s case.” ECF No. 131 at 29. The
theory of causation at issue in Cedillo was whether the MMR vaccine and TCVs, acting together,
can cause autism. More importantly, as the Government points out, Dr. Zimmerman authored
his Cedillo report more than one year after he co-authored the Poling paper. Id. So, “he must
have found no conflict between the suggestion in the [Poling] case note that there might be a link
between immunizations and autism in children with mitochondrial disorders” and the connection
between MMR vaccines and autism. ECF No. 123-3 at 6. As there were different issues being
tested, DOJ “did not use Dr. Zimmerman’s Cedillo opinion improperly in other cases.” ECF No.
131 at 24. And Dr. Zimmerman “never asked [DOJ] not to use his opinion in other OAP cases.”
Id. (emphasis omitted).

This conclusion is bolstered by Dr. Zimmerman’s recognition that DOJ attorneys told
him that his Cedillo opinion would be used as general causation evidence in other Theory 1 cases
and by the fact that the PSC “never asked any witness about” the mitochondrial dysfunction
theory, nor did any of its witnesses offer the theory. ECF No. 131 at 10; ECF No. 123-3 at 22.
And Yates was not diagnosed with an underlying mitochondrial dysfunction until several years
after Hazlehurst concluded, so the court struggles to see how the mitochondrial dysfunction
theory could have impacted the decision. See ECF No. 123-7 at 4–5.

21
Third, DOJ did not attempt to conceal Dr. Zimmerman’s opinion in any other case. He
presented his mitochondrial dysfunction theory in several other cases: Murphy, Madariaga, and
Reed, to name a few. See supra at 16. In each case, the Special Master rejected the
mitochondrial dysfunction theory that Dr. Zimmerman presented in each case. This is important
for two reasons. First, it shows that the Government did nothing to prevent Dr. Zimmerman
from presenting his mitochondrial dysfunction theory. Second, it shows that when he did present
his theory the Special Masters found it unpersuasive, which supports the conclusion that it would
not have changed the outcome here. Sierra Pac., 862 F.3d at 1168 (explaining that a fraud on
the court claim cannot survive if it does not affect the outcome of the case). True, Paluck stands
to the contrary. But one case among many, involving a theory not at issue in the OAP, does not
persuade the court to the contrary given the significant burden that the Petitioner must overcome
to establish fraud on the court.
Fourth, Dr. Zimmerman’s expert report played almost no role in either Cedillo or
Hazlehurst. Special Master Hastings in Cedillo cited Dr. Zimmerman once; Special Master
Campbell-Smith in Hazlehurst cited him twice. And each explicitly stated that they gave more
weight to the testifying experts. To be sure, Special Master Vowell in Snyder did cite to Dr.
Zimmerman several times, but mostly to explain the varying views of the evidence. So, even if
Dr. Zimmerman did testify, his testimony would not likely have changed Special Master
Hastings’s decision. Again, the Petitioner’s burden requires much more.

The Petitioner disagrees. He argues Dr. Zimmerman’s testimony “would have changed
the outcome of the OAP test cases” because the “Special Masters clearly relied upon the DOJ’s
fraudulent misrepresentations concerning Dr. Zimmerman’s opinion.” ECF No. 132 at 16. Not
only that, but Dr. Zimmerman “was unquestionably [DOJ’s] most qualified expert on the subject
of autism.” Id. at 17. He also says DOJ’s withdrawal was prejudicial, “demonstrating the
importance of Dr. Zimmerman’s opinions,” because it contributed to Special Master Campbell-
Smith’s decision to not “decide whether there was such a thing as regressive autism.” Id. The
non-withdrawal of the expert report coupled with DOJ’s statements during closing argument
regarding Dr. Zimmerman’s opinion magnified the fraud on the court, the Petitioner says. ECF
No. 118 at 32. Specifically, he says DOJ intentionally misled OSM about the expert opinion,
and it was relied on because “the Special Master cited the exact same portion of Dr.
Zimmerman’s expert opinion that [DOJ] quoted in closing.” Id. Finally, the Petitioner points to
the OPR response, where it concluded that DOJ “kept his report in the record, figuring that if the
report were withdrawn, it would suggest that Dr. Zimmerman was not called because he had
changed his opinion.” Id. at 30. That admission “is evidence of DOJ’s intent to defraud the
[c]ourt.” Id.

But one look at the decisions at the OAP dispels any materiality concern, so even if DOJ
could be faulted for failing to disclose Dr. Zimmerman’s theory, it was not material. Indeed, this
case is like the many unsuccessful fraud on the court claims based on such failure. Take Fox, for
example, where a coal company’s law firm withheld certain pathology reports and failed to
disclose all relevant medical evidence. But there was no fraud on the court because it was not
part of an intentional design to undermine the court’s integrity. Fox, 739 F.3d at 137–39.
Similarly, in Wilson the plaintiff alleged that the defendants concealed asbestos dangers but there
was no fraud on the court because it was merely nondisclosure. 873 F.2d at 872. And in ESM
Group, counsel failed to disclose important jurisdictional information, but no fraud on the court

22
occurred because the information merely would have been helpful in the opposing party’s
defense, and, at best, went to witness credibility. 835 F.2d at 273–74.

Those results aid in the court’s decision here. At most, the failure to withdraw Dr.
Zimmerman’s expert report is a failure to disclose his caveat that his opinion was case-specific.
A failure to disclose, without more, is not fraud on the court. Instead, it is “garden-variety”
matter meant to be addressed either during the proceeding or under Rule 60(b) within one year of
the judgment. See RCFC 60(b)–(c) (explaining that a motion for relief from a final judgment
based on mistake, newly discovered evidence that could not have been earlier discovered, or
fraud must be brought within one year). Or it is a “tactical litigation decision” that is not an issue
under Rule 60 at all. Litigants may decide which witnesses to present; choosing not to put an
expert on the stand is a common one.
In any event, the PSC had the Poling paper in the OAP record and could have questioned
witnesses about it if the PSC thought it was relevant. This underscores the absence of intentional
deception or concealment. Such a peripheral piece of evidence, raised but not pursued, had no
apparent impact on the outcome or on the court’s ability to adjudicate impartially. In sum, the
key hallmarks of fraud on the court are absent: there was no intentional deception of the Special
Masters or any of the judges hearing these cases, no scheme to interfere with the judicial
machinery, and no material falsehood affecting the proceeding. Rather, this involved ordinary
trial tactic and a minor evidentiary discrepancy that was ultimately moot. See Cleveland
Demolition Co. v. Azcon Scrap Corp., 827 F.2d 984, 985–86 (4th Cir. 1987) (explaining that
strategic litigation decisions are not fraud on the court ); Fox, 739 F.3d at 137 (“Conduct that is
not exemplary need not undermine the ‘integrity of the court and its ability to function
impartially’ within the meaning of ‘fraud on the court.’” (quoting Great Coastal Express, 675
F.2d at 1356)).
To be sure, quoting from Dr. Zimmerman’s expert report after choosing not to call him to
testify may not be the way all lawyers would have handled the OAP litigation, but the court
disagrees with the Petitioner that it “had wide-ranging implications to all OAP cases.” ECF No.
118 at 10 (emphasis omitted). This does not rise to fraud on the court.

The Petitioner relies on Hazel-Atlas for several “principles.” He says the Hazel-Atlas
recognized that “(1) every court has the inherent power to vacate a judgment obtained by fraud
on the court; (2) the court that was the victim of the fraud should consider the matter; and (3)
there is no time limit on setting aside a judgment on this ground.” ECF No. 118 at 27–28 (citing
Hazel-Atlas, 322 U.S. at 238). The court agrees with these points. The Petitioner also notes that
“[o]ne of the primary reasons justifying relief under the fraud on the court doctrine . . . is ‘an
injury to more than a single litigant that assaults the integrity of the judicial process.’” Id. at 34
(citing Hazel-Atlas, 322 U.S. at 246). The court likewise agrees with that point. But the court
does not agree that “the facts of [Hazlehurst] are similar to” Hazel-Atlas, ECF No. 132 at 18–19,
because no fraud on the court occurred here. In Hazel-Atlas, lawyers authored a fake article that
purported to be from a neutral expert in support of a patent, and that article was relied on
tremendously, “for the deliberate purpose of deceiving the Patent Office” into awarding them a
patent. 322 U.S. at 250. No similar activity or malfeasance occurred here. DOJ made a
litigation decision that, even if faulted, was not material to the OAP or subsequent court
decisions.

23
In the end, this was not fraud on the court. The alleged fraud, was not “the most
egregious conduct” that “prevented the functioning of the judicial process.” Nor was there any
misconduct that prevented the PSC from fairly presenting its case, and the court was not
materially misled.

b) DOJ and HHS did not secretly concede Poling to prevent it from
becoming a test case, nor did it improperly suppress the Rule 4 report.

The Petitioner next argues that “DOJ and HHS secretly conceded the Poling case to
prevent it from becoming a test case, because the HHS expert would have revealed evidence of
how vaccines cause autism.” ECF No. 118 at 6. He likewise argues that DOJ and HHS
improperly suppressed Dr. Zimmerman’s expert report (submitted in support of the argument
that seizures were a product of vaccines) and changed the basis of compensation “to conceal
fraud and critical material evidence of how vaccines cause autism.” Id. at 18.

First, it is clear DOJ conceded Poling as a Table injury, undermining many of the
Petitioner’s claims. Poling “was compensated on the presumption of causation that attaches
when the Table injury requirements are met, not on actual causation or causation in fact basis.”
R.K., 2015 WL 10911950, at *17 (emphasis omitted). The Rule 4 reports refer to an injury
appearing on the Table. That reference would be “nonsensical, as the only injuries that appear
on the Table are those for which entitlement to compensation is presumed, such as the MMR
Table injury of encephalopathy.” Id. Thus, the argument that the statements made by Special
Master Campbell-Smith regarding the grounds on which the case was conceded as “inconsistent
with both the original and Supplemental” Rule 4 reports is rejected. ECF No. 118 at 19.

Second, Dr. Zimmerman’s expert report in Poling did not impact the government’s initial
concession in that case nor the decision in Hazlehurst. Dr. Zimmerman’s Poling expert report
“was filed after the case was conceded in the Rule 4 report, [so] it could not possibly have been a
factor in respondent’s decision to concede entitlement to compensation on the basis of a Table
injury.” See R.K., 2015 WL 10911950, at *22 (finding that “the Zimmerman report was not
what prompted the respondent to concede the Poling case”). And different theories of causation
were considered in each: in Hazlehurst, whether a combination of the MMR vaccine and TCVs
could cause autism; in Poling, whether vaccines could aggravate an underlying mitochondrial
condition, leading to regressive autism. So the concession could not have played any role in
Hazlehurst.

Third, the report by Dr. Zimmerman suggests that vaccines significantly aggravated a
mitochondrial disorder, resulting in regressive autism. That opinion was not suppressed at any
point for the reasons described above, and it is one that has been consistently rejected. So the
argument that DOJ concealed “Dr. Zimmerman’s . . . opinion[] explaining how vaccines cause
autism in some children” cannot survive. ECF No. 118 at 15. Dr. Zimmerman also “was
unaware of any effort by any Department attorney to suppress his opinion in Poling, and that no

24
one from the government had ever asked him not to share or discuss it with anyone else.” 17 ECF
No. 123-3 at 14.

Finally, even assuming everything the Petitioner argues regarding the Rule 4 reports is
true, he would still fail to establish fraud on the court. Special Master Campbell-Smith saw
everything: the initial Rule 4 report, the supplemental Rule 4 report, and the supplemental
memorandum. She concluded that the Poling concession was for a Table injury. The merits of
her conclusion are not the issue before this court; the question is whether there was fraud on the
court about whether the Government settled the Poling case as a Table or Off-Table injury.
Given the Special Master’s full awareness of everything in each of the three documents when she
made her decision, any change the Government may have made in those documents cannot have
constituted a fraud on the court. See Dobyns, 127 Fed. Cl. at 69 (citations omitted) (explaining
that the fraud “must have actually deceived the court”).

2. DOJ did not commit fraud on this court.

The Petitioner also argues that DOJ committed fraud on this court when the PSC moved
for review in Hazlehurst. ECF No. 118 at 19–20. The petition asserted, among other arguments,
that the Special Master improperly declined to decide whether regressive autism is distinct from
classic autism. Hazlehurst, 88 Fed. Cl. at 478. The Special Master did not decide whether a
distinction existed because that distinction rested on two predicates that the PSC failed to prove,
so it was unnecessary. See Hazlehurst, 2009 WL 332306, at *24 (explaining that she need not
reach the distinction issue because she was “[u]npersuaded that childhood vaccines lead to the
development of autism”). The several studies on which the PSC’s main expert relied upon for
the distinction were “widely discredited by the scientific community,” and “the testing
conducted” at the labs “contained procedural flaws that compromised their reliability.”
Hazlehurst, 88 Fed. Cl. at 478. So, the expert’s opinion “could not be credited as sound or
reliable,” meaning the PSC’s causation theory was “premised upon a series of biological
implausibilities.” Hazlehurst, 2009 WL 332306, at *13, *149. During oral argument, DOJ
argued that the Petitioner was “basically assigning error to the Special Master by saying that she
failed first to consider whether regressive autism is causally distinct from classic autism is their
word. But the fallacy in that argument is that they didn’t give her any evidence that there is a
distinct cause.” ECF No. 122-3 at 14:11–16. This court denied the petition for review.
Hazlehurst, 88 Fed. Cl. at 475.

The Petitioner makes a few arguments that this court’s prior decision was polluted by
fraud, largely premised on the “fraud” that led to a favorable decision for DOJ in the Cedillo and
Hazlehurst OAP hearings. First, the Petitioner argues that in denying the prior petition, the court
“did not and could not have known or considered that Dr. Zimmerman had materially modified
his general causation opinion or that the DOJ had perpetrated fraud.” ECF No. 118 at 20. He
17
While the Petitioner argues that the Special Masters “knew or should have known” that Dr.
Zimmerman’s written expert opinions “completely conflict,” ECF No. 118 at 35, the argument
carries little weight. Dr. Zimmerman’s opinions present different causation theories that he did
not believe “completely conflict.” He authored his expert report in Cedillo one year after the
publication of the Poling paper. ECF No. 120-2 at 8. Nor has he ever rescinded in full his
Cedillo opinion. Thus, he did not think that his two opinions “completely conflict.”

25
repeats the argument that fraud occurred, as DOJ attorneys “were well aware of Dr.
Zimmerman’s revised opinion that vaccines can cause regressive autism and participated in
DOJ’s fraudulent scheme to conceal and misrepresent his opinion.” Id. This argument fails
because no fraud occurred regarding Dr. Zimmerman, for the reasons described above.

Second, the Petitioner argues that fraud on the court occurred because “DOJ attorneys
knew their arguments to [the Court of Federal Claims] were deceptive because they signed the
original Poling Rule 4(c) Report and subsequently received Dr. Zimmerman’s supplemental
expert opinion dated November 30, 2007, before executing the Supplemental Poling Rule 4(c)
Report on February 21, 2008.” Id. at 33. But, as explained above, the Government conceded
Poling as a Table injury, meaning no causation determination was made because causation is
presumed in Table injury cases.

Third, the Petitioner argues that the court’s faulting him for the failure to provide
evidence regarding whether there are distinct causes for classic and regressive autism was the
result of fraud. He contends that what DOJ “failed to acknowledge, however, was that the DOJ
hid this very evidence from [the Petitioner] and the Special Master.” Id. at 20 n.62. This
argument fails because DOJ did not hide any evidence, and no wrongdoing occurred with Dr.
Zimmerman’s opinion. Again, the Poling paper addressing Dr. Zimmerman’s mitochondrial
dysfunction theory was in the record long before Hazlehurst began.

In the end, the conduct before this court, even if the court could construe it as improper,
falls well short of “the most egregious misconduct, such as bribery of a judge or members of a
jury, or the fabrication of evidence by a party” that is required to establish a fraud on the court.
Rozier v. Ford Motor Co., 573 F.2d 1332, 1338 (5th Cir. 1978) (quoting United States v. Int’l
Tel. & Tel. Corp., 349 F. Supp. 22, 29 (D. Conn. 1972)).

3. DOJ did not commit fraud on the Court of Appeals for the Federal Circuit.

The Petitioner next argues that DOJ committed fraud on the Federal Circuit during oral
argument in Hazlehurst. The panel asked the DOJ attorney about developing science and
medicine regarding whether vaccines can cause autism. ECF No. 122-6 at 3–4. She responded,
“at this stage, [] we’re not even at the stage where it’s medically or scientifically possible.” Id.
OPR interviewed that lawyer, and explained, “[i]n retrospect, she regarded her response as
slightly inaccurate, ‘not because of anything to do with Dr. Zimmerman, [or] the Poling case,’
but rather because she now ‘appreciate[s] that science does not work in absolutes. Anything is
“possible” in science.’” ECF No. 123-3 at 18. OPR found the comment to be a “mistake” not
meant to mislead the court, but “made in the tense and unrehearsed atmosphere of an appellate
oral argument, without time to carefully prepare” remarks. Id. at 24.

These answers amounted to fraud on the court, the Petitioner says, because they were
“exceptional and provably false statements of material fact.” ECF No. 118 at 33. Not only that,
the lawyer “knew that her statements . . . were [false] because she had signed the Poling Rule
4(c) Report conceding vaccine injury caused regressive autism in Poling, which is primarily
based on Dr. Zimmerman’s expert opinion.” Id. These “intentional false statements to the Court
of Appeals were part of a larger plan and scheme to conceal the truth as to the central issue of the
OAP[.] . . . [Her] false statements were made with the intent to deceive the court and to affect

26
the outcome.” Id. at 34 (internal footnote omitted). And “[i]f the DOJ is allowed to perpetrate
such a boldfaced lie to the Court of Appeals regarding the central issue of the OAP, then it
completely undermines the integrity of the courts and the entire American legal system.” Id.
These conclusory statements do not turn these statements into a fraud on the court. But again,
nothing involving Dr. Zimmerman amounted to fraud on the court. And the same is true of the
Poling concession.

Materiality is also a necessity, so the court turns to the Federal Circuit’s decision in
Hazlehurst to analyze the issues it decided and why. On appeal in Hazlehurst, the Petitioner
argued “that the special master improperly relied on certain evidence that should have been
excluded and disregarded other evidence that should have been considered.” 18 Hazlehurst, 604
F.3d at 1345. “[T]he linchpin of their theory was the discovery of persistent measles virus in
certain autistic children who had received the MMR vaccine.” Id. at 1346. That evidence
derived from research that has been heavily discredited. 19 Id. at 1347. This court rejected the
argument, and the Federal Circuit followed the same path: Special Master Campbell-Smith
complied with her statutory directive to conduct a fair proceeding. Id. at 1349. Furthermore,
neither this court nor the Federal Circuit mentioned Dr. Zimmerman’s expert report. And, of
course, neither address mitochondrial dysfunction. Nor did either note the DOJ lawyer’s
statement about “[not even being] at the stage where it’s medically or scientifically possible” for
vaccines to cause autism. Given this lack of reliance, no fraud on the court occurred. There
simply is no basis to conclude that the conduct at the Federal Circuit rises to the level of fraud on
the court.

4. DOJ did not commit fraud on the Supreme Court of the United States.

In Bruesewitz, the Supreme Court held that the Vaccine Act expressly preempts design
defect claims. So long as vaccines are accompanied by proper directions and warnings, vaccine
manufacturers are not liable for vaccine-induced injury or death. Bruesewitz, 562 U.S. at 231–
34. In other words, the Vaccine Act’s provisions still govern.

The Petitioner argues that the decision was procured by fraud. His argument goes like
this: (1) Because DOJ concealed Dr. Zimmerman’s mitochondrial dysfunction theory at the

18
As for the evidence that “should have been excluded,” the OSM gave the PSC an extra year to
rebut it, but the PSC chose not to. Hazlehurst, 604 F.3d at 1347. As for the evidence that
“should have been considered,” the OSM gave it appropriate weight. See id. at 1352 (explaining
that the Special Master “accord[ed] little weight” to the evidence because of the study’s severe
and several shortcomings). Importantly, it would have made no difference in the Federal
Circuit’s decision.
19
The researchers’ behavior was concerning. They “tested degraded genetic material rather than
discarding it” and “used inconsistent procedures to extract and evaluate the genetic material.”
Hazlehurst, 604 F.3d at 1348. They “omitted key steps necessary to prepare samples” and
“failed to heed the equipment manufacturer’s instruction[s].” Id. They also “reported positive
findings, rather than re-running tests, when duplicate assays showed inconsistent results.” Id.
Testimony also suggested contamination. Id.

27
OAP, the PSC lost; (2) The respondent in Bruesewitz made policy arguments that allowing
vaccine manufacturer liability for design defects could lead to a flood of financially-crushing
litigation and cited the OAP as an example of such potential; (3) The majority relied on the
policy argument for its ruling, so if the PSC succeeded at the OAP, the Supreme Court would
have ruled otherwise. See ECF No. 118 at 21–23; Brief for Respondent at 56–57, Bruesewitz,
562 U.S. 223 (2011) (No. 09-152), 2010 WL 2962899, at *56–57 (noting that, after the OAP
concluded and found no link between the vaccines at issue and autism, a contrary result in
Bruesewitz might “embolden[]” “claimants in the [OAP] . . . to pursue a flood of civil actions”).

Justice Breyer concurred, focusing partially on some policy concerns that some amici
posited (and cited to Hazlehurst and the OAP). Bruesewitz, 562 U.S. at 247–49 (Breyer, J.,
concurring). In dissent, Justice Sotomayor pointed to the policy arguments advanced by the
respondent, and that that concern “underlie[s] the majority and concurring opinions.” Id. at 274
n.25 (Sotomayor, J., dissenting). She did not seem worried about the policy implications,
deeming them “remote.” 20 Id.

The Petitioner’s theory contains a series of inferential leaps that the court cannot make.
To begin, the court has established that DOJ did not conceal Dr. Zimmerman’s opinion on the
mitochondrial dysfunction hypothesis, and the Poling paper was not material to the OAP
decisions. Indeed, there is no basis for the court to conclude that the OAP’s results would have
changed had Dr. Zimmerman testified during Cedillo. Given his testimony failed to persuade
Special Masters when he did present it, this court cannot conclude that “a single policy argument
was dispositive of the holding in that case is ‘wholly speculative and highly dubious.’” ECF No.
131 at 36 (quoting ECF No. 123-3 at 24–25). It falls well short of the high bar that the Petitioner
must clear to establish fraud on the court.

5. DOJ is not continuing to perpetrate fraud on the court.

The Petitioner also argues that DOJ continues to perpetrate fraud on the court. ECF No.
118 at 25–26; ECF No. 132 at 15–16 (arguing that DOJ is committing a fraud on the court still
because it is “[a]ctively misrepresenting and making false statements to this [c]ourt regarding
changing the basis of compensation in Poling”). For the same reasons described above regarding
the purported misrepresentations to Special Master Campbell-Smith, this argument fails. She
had all of the documentation in front of her and made an informed decision. That is not fraud.

B. Petitioner may not challenge the constitutionality of the Vaccine Act in a
Rule 60(d) motion.

Finally, the Petitioner argues that the Vaccine Act violates his right to due process and
equal protection. ECF No. 118 at 38–39. On his understanding of the Act, Congress placed
injured vaccinees “into a subclass of citizenship” by “nationaliz[ing] the vaccine program and
forc[ing] the injured into an administrative program, depriving them of the most basic judicial
processes, including the right to a judge, jury, the rules of civil procedure, discovery, and

20
The Petitioner says Justice Sotomayor “particularly focused” on the OAP and policy
arguments. ECF No. 118 at 22. That is not the case. She references the OAP in one footnote.

28
evidence.” Id. at 39. If this were not the case, he says Dr. Zimmerman’s opinion “would likely
have been exposed if the ordinary rules of evidence and the ability to cross-examine witnesses
had been available.” Id. Finally, he says that “the restrictions of the Vaccine Act render the
right to appeal to courts of law essentially meaningless in all but the rarest of cases.” Id. The
Petitioner cites no authority for his propositions.

But the Petitioner cannot use a motion alleging fraud on the court to challenge the
constitutionality of the Vaccine Act nearly 16 years after judgment. Fraud on the court cases
make clear that courts must appreciate the finality of judgments, see Hazel-Atlas, 322 U.S. at
244, and that fraud on the court is not meant to be used to revisit a statute’s validity. The
Petitioner had every opportunity to raise a constitutional challenge during the original
proceedings, whether before this court or the Federal Circuit. Those avenues have long since
closed. Judgments, once final, must remain final unless fraud on the court is proven. And here,
no such fraud occurred. See supra at 21–29. Thus, the constitutionality claims must also be
rejected.

Even if the Petitioner could raise his constitutional arguments, they would fail. As an
initial matter, for the reasons described above, Dr. Zimmerman’s opinion was not concealed, so
there was nothing to “expose.” Even so, the Petitioner’s due process and equal protection
arguments would fail for another reason—the Petitioner’s premise that vaccine petitioners are
relegated to some second-class status without due process or equal protection rights is without
merit. The Act provides a low cost and often easier process to petitioners seeking to recover for
vaccine injuries. E.g., Shalala, 514 U.S. at 269. It did not bar the Petitioner from bringing his
case to other courts.

Consider the text of the Act. Petitioners must first bring their claims to the OSM, and the
Act provides a right of review in this court and the Federal Circuit. See 42 U.S.C. § 300aa-
12(e)–(f). If the OSM does not issue a decision within 240 days of the filing of the petition, the
petitioner may elect to leave the program and sue elsewhere under state law. Id. § 300aa-
21(b)(1). 21 And if this court does not enter judgment within 420 days of the initial petition, the
petitioner may also elect to leave the program and sue elsewhere under state law. Id. § 300aa-
21(b)(2). An unhappy petitioner can even elect to leave the program and seek relief elsewhere
after this court’s judgment becomes final. Id. § 300aa-21(a); Terran, 195 F.3d at 1307 n.1. 22
The only limitation is that such a claim must “be brought within the period prescribed by
limitations of actions” under the applicable state law. 42 U.S.C. § 300aa-21(c). Congress
protected court access here as well—any state law statute of limitations is stayed from the date
the petition is filed with OSM until the petitioner elects to leave the program. Id. § 300aa-16(c).
Taken together, the Act does not prohibit any petitioner from pursuing claims under state law in
other venues if he or she chooses.

21
There are certain periods that are exempted from the calculation of these timing provisions.
See 42 U.S.C. § 300aa-21(b).
22
If a petitioner thinks that a final monetary judgment is too low, he or she may elect to forgo
this court’s judgment and sue elsewhere. Id. § 300aa-21(a)(1).

29
As the First Circuit explained, the Act:

discourages victims from bringing those traditional tort cases by
providing fairly generous, more easily obtainable, Vaccine Court
awards. A victim who obtains such an award may hesitate to give
up that bird in the hand in return for a larger, but more speculative,
tort law award. And, a petitioner to whom the Vaccine Court gives
nothing may see no point in trying to overcome tort law’s yet more
serious obstacles to recovery.

Schafer v. Am. Cyanamid Co., 20 F.3d 1, 4–5 (1st Cir. 1994). This is not unconstitutional. Milik
v. Sec’y of Health & Hum. Servs., 822 F.3d 1367, 1378 (Fed. Cir. 2016) (rejecting the argument,
based in part on Bruesewitz, that the Vaccine Act is unconstitutional); Terran, 195 F.3d at 1311
(rejecting a constitutional challenge to the Act); H.L. v. Sec’y of Health & Hum. Servs., 129 Fed.
Cl. 165, 176 (2016) (“[T]he Vaccine Act does not deny a Petitioner access to an Article III
court.”). Thus, even if the Petitioner could bring his constitutional challenges now, they would
fail.

***

A court must enforce a judgment unless it “clearly proves . . . to be against conscience.”
Marine Ins. Co. v. Hodgson, 11 U.S. 332, 336 (1813) (Marshall, C.J.). That occurs when a party
shows its adversary “sentiently set in motion some unconscionable scheme calculated to interfere
with the judicial system’s ability impartially to adjudicate a matter by improperly influencing the
trier of fact of unfairly hampering the presentation of the opposing party’s claim or defense.”
Aoude II, 892 F.2d at 1119. Because the Petitioner has not met his heavy burden, his claim of
fraud on the court fails.

IV. Conclusion

For these reasons, the court DENIES the Petitioner’s motion for relief from judgment,
ECF No. 118.

It is so ORDERED.

s/ Edward H. Meyers
Edward H. Meyers
Judge

30

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/11101498. Public record. Not legal advice.